Please login to the form below
Lars Rebien Sørensen becomes chairman of Novo Holdings
He will take up the new role 1 July
Former Novo Nordisk CEO Lars Rebien Sørensen has been appointed as Novo Holdings’ new chairman.
He said: “In recent years, Novo Holdings has significantly increased its investments and influence in the global life science sector.
“I consider it to be a great responsibility to lead the continued growth of Novo Holdings as it plans to further increase its investments in life science companies in the coming years.
Sørensen will succeed Sten Scheibye - who retires effective 1 July - and he will also become chairman of the board of the Novo Nordisk Foundation.
Featured jobs
- Principal Medical Writer / Editorial Director – Medical Communic...
-
£60, 000 - £80, 000
-
Market Access Consultant - Cheshire
-
Negotiable
- Senior Project Manager - Medical Writing
-
Great salary and bebefits
-
Account Manager
-
£40, 000 - £45, 000 benefits
-
Scientific Director
-
Great salary and bebefits
- Freelance Senior Account Manager – healthcare advertising
-
Employment Type:. Healthcare Advertising Jobs. Salary:. 250 to 320 per day
-
Senior Medical Writer
-
Great salary and benefits
- Science Writer, Healthcare Advertising Agency
-
£40, 000 - 45, 000 DOE benefits,
-
Senior Medical Writer
-
Great salary and bebefits
-
Medical Director
-
Excellent benefits
- Senior Account Manager / Account Director
-
Great salary and bebefits
- Multi-Channel Account Managers - Road / Homebased – Full or Part...
-
starting from £32, 500
- Account Director, Healthcare Communications Agency
-
£54, 000- £60, 000
- Account Director or Senior Account Director
-
Salary TBC
Subscribe to our email news alerts
- How can pharma engage with key stakeholders on NHS service transformation?
- The race for an HIV ‘cure’
- Medopad: the up and coming unicorn transforming remote patient monitoring
- Novo spends $800m to buy biotech and 'glucose responsive insulin' tech
- Daily Brief: Biosimilar Herceptin can't make Perjeta cost effective and more
- Armoured CAR ‘could overwhelm solid tumour resistance’
PMHub
Frontera Group
Welcome to Frontera Group where our agencies immerse you into the world of the patient....
Latest intelligence
- How can pharma engage with key stakeholders on NHS service transformation?
- Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare consulting team, explain how pharma should make its case for change...
- The race for an HIV ‘cure’
- Supercharging therapies as pharma and patients work together...
- Medopad: the up and coming unicorn transforming remote patient monitoring
- Blue Latitude Health speaks to Medopad’s Martha Carruthers to learn how the start-up’s modular apps are helping patients with complex diseases....
Quick links
Infographics
